200,000+ products from a single source!
sales@angenechem.com
Home > Pyridines > 173529-46-9
CAS No: 173529-46-9 Catalog No: AG001Z05 MDL No:MFCD12756255
| Title | Journal |
|---|---|
| Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | The oncologist 20090601 |
| A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumors. | Clinical cancer research : an official journal of the American Association for Cancer Research 20060901 |
| What's new in pancreatic cancer treatment pipeline? | Best practice & research. Clinical gastroenterology 20060401 |
| In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176. | Investigational new drugs 20031101 |
© 2019 Angene International Limited. All rights Reserved.